NCT05352698View on ClinicalTrials.gov

Validation of B-type Natriuretic Peptide With N-terminal Pro B-type Natriuretic Peptide in Perioperative Risk Assessment

CompletedOBSERVATIONAL

Enrollment

466

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Perioperative Care

Interventions

DIAGNOSTIC_TEST

NT ProBNP (Roche)

This NT ProBNP assay is a point-of-care (POC) test that will be conducted on a 2 mL sample of whole blood collected in a non-heparinized tube. NT ProBNP results are used in this setting to predict perioperative cardiovascular risk.

Trial Locations (1)

K0H1S0

Kingston Health Sciences Centre, Kingston

All Listed Sponsors

lead

Jordan Leitch

OTHER